Pumpers Stay Up Late for DMH International, Inc. (OTC:DMHI)
Last night pumpers stayed up late to bring their subscribers news that DMH International, Inc. (OTC:DMHI) have received FDA approval for their product. Despite the efforts of promoters over the last three days, DMHI has crashed over 80%.
The last promotional emails came through in the small hours last night, touting a news release by the company that their Touchpacs medical software suite has received FDA approval. It’s more than a little weird that a company will update their website past midnight, as the news post is timestamped March 1. But desperate times call for desperate measures, it seems.
DMHI‘s stock was completely obliterated after pumpers started touting it on Feb 27, speaking of bounces and issuing special alerts that never lifted the stock. DMHI was an entity that had generated no revenues since inception according to their last filed quarterly report, consistently logging moderate net loss. General and administrative fees for fiscal Q3 of 2012 were 260 dollars, a sum that gives the impression of a non-functioning entity.
The pumps for DMHI started when the company announced a merger with Touch Medical Solutions, Inc. – a company developing medical imaging software. Investors may find it also very curious that DMHI has been keeping strange company. DMHI‘s S-1 registration statement lists the name of Carrillo Huettel, LLP as the company’s legal counsel. The same legal firm is listed on DMHI‘s OTCMarkets page.
Carrillo Huettel, LLP happens to be the name of the legal counsel entity that was associated with some of the truly ugliest pump jobs over the last year that ended in complete disaster. Before closing their U.S. offices towards the end of 2012, Carrillo Huettel were associated with stocks that were pumped and later lost millions worth of investor cash such as Southridge Enterprises, Inc. (PINK:SRGE), Pub Crawl Holdings, Inc. (OTC:PBCWE), and Pristine Solutions, Inc. who are now trading under their new name Eaton Scientific Systems, Inc. (PINK:ESSI). The charts linked under the ticker symbols should prove sufficient visual aid.
As far as the announced FDA approval is concerned, the records held by the FDA show that 510(k) clearance was given as early as January 6. The fact that DMHI decided to announce this as news now, after the stock has crashed horribly, is either very peculiar timing, or a move that has other intentions behind it, which we can only guess at.
Investors are advised to do their own thorough due diligence before putting their money in any stock, even more so if it’s a promoted recent merger that is already going downhill.
